Scenarios and Signals
Reconciling the case, and the signals that settle it
Having traced a cash-generative scale leader now trading below book, the report reaches the question no single chapter settles: whether that discount is durable impairment or a cyclical trough. This closing chapter does two things the earlier ones could not: it reconciles the bull and bear reads on the same shared facts, and it names the dated, observable signals that will decide between them.
Figures are shown in renminbi (RMB) with U.S.-dollar equivalents at the roughly RMB 6.99 = US$1.00 convenience rate used in the FY2025 20-F, or the RMB 6.898 rate in the Q1 2026 release for that quarter; ratios and growth are currency-independent. The ADS reference price is US$13.38 (27 Jul 2026). Each citation links to the source page.
The evidence, reconciled
Every load-bearing fact in this report reads two ways depending on whether the 2025–26 decline is cyclical or structural. Setting the bull and bear interpretations against the same number — rather than against each other's rhetoric — is what shows how little separates them and how few observations would decide it.
Sources: valuation and returns, FY2025 20-F Consolidated Balance Sheets and Statements of Operations [1] [2]; reserve sensitivity p.157 [3]; regulation p.108 and Q4 2025 call [4] [5]; Q1 2026 credit metrics [6]; parent cash p.270 [7].
The reconciliation the earlier chapters build to is this. On valuation and reserves, the circularity the earlier chapters isolate (Margin of Safety, Reserve Quality) is exact: Qifu trades at 0.47x book (US$1.63bn market value vs US$3.45bn equity) and ~1.9x trailing earnings, yet both the book and the earnings are set by a single unverifiable input — the expected-default estimate Deloitte named its sole 2025 critical audit matter — whose 0.5-percentage-point move swings reserves by RMB753.6m (~13% of the RMB5,989.7m net income), so the asset floor is not independent of the earnings risk it is meant to cushion, and only ~US$74m of the group's cash sits at the listed parent. [8] [9] [10]. On the franchise, Qifu is the empirical scale leader of the listed Chinese credit-tech group — RMB327.1 billion (US$46.8 billion) of 2025 volume across 63.6 million credit-approved users (Scale and Moat) [11] — but that scale runs through a funding channel regulators now gate, and the capital-light referral engine that best expressed it contracted sharply once the whitelist rules landed (Whitelist Regime) [12]. The two sides are not arguing about different facts; they are weighting the same ones toward different endings.
Three ways the next two years run
The case is most sensitive to the credit path — whether the improvement in the leading indicators shown in Leading vs Lagging reaches the loss line, or the back book keeps the realized 90-day-plus rate climbing. That single variable, more than valuation or regulation, separates the three scenarios below. The valuation frames are illustrative arithmetic anchored to the US$3.45 billion book and the RMB5,989.7 million 2025 profit, not price targets; each moves with the driver named beside it.
Source: scenario arithmetic derived from FY2025 net income and book equity [13] [14]; 2026 consensus (~-37% net income) and the ~US$22 analyst price-target mean are from consensus data, as reported.
The distances between these outcomes are wide but bounded, and the arithmetic makes the asymmetry concrete. In the base case, a company earning even a flat ~US$540 million and returning cash at more than half its market value a year compounds a large return from a 0.47-times-book start, with the dividend alone near 12% of the price (Margin of Safety) [15]. The bear case is not a zero — it is a business that keeps earning but at a mid-single-digit return on equity, where a sub-book multiple is deserved and book value itself leaks as reserves rebuild off the same estimate that governs earnings [16]. The sell-side, with a mean target near US$22 against the US$13.38 quote, is priced roughly to the base case; the shares are priced closer to the bear.
What to watch
The scenarios resolve on a small set of observations, each attached to a specific filing line, a window, and a threshold that would move the read. They are ordered by how cleanly each one discriminates between the cyclical and structural stories.
Sources: profit-floor guidance and buyback status, Q1 2026 results release and call [17] [18]; delinquency and take-rate metrics, Q1 2026 call [19]; whitelist and Sep-2026 online-marketing measure, FY2025 20-F [20]; Aug-2026 comprehensive-cost Provisions, per peer FY2025 20-F [21]; overseas expansion, Q1 2026 call [22].
The top two are the ones that most cleanly settle the through-line. If the 90-day-plus rate — the realized, not modeled, metric a skeptic trusts — peaks and rolls over in the second half of 2026 while the non-GAAP profit holds the floor management guided, the cyclical-trough reading strengthens and the base case comes into view [23] [24]. If instead the 90-day-plus rate keeps climbing past 3.5% while the profit floor gives way, the durable-impairment case is the one the evidence supports. The buyback is the tell on management's own conviction: with roughly US$0.71 billion of net liquid assets on hand, resuming repurchases at today's sub-book price would create per-share value rather than merely distribute cash, and its absence would say management sees the risk the bear does [25].
What the corpus cannot settle
Three questions matter to the outcome and cannot be answered from the filings to date, so they belong on the watch list rather than in the analysis as fact.
The first is whitelist inclusion. The 20-F flags exclusion from partner banks' whitelists as a risk but does not disclose whether Qifu is actually on those lists; with the top five bank partners supplying about 35.1% of 2025 funding, a confirmed inclusion would move the funding-access bind from medium toward benign, and a material exclusion the other way [26]. The second is the durability of the funding cost: with on-balance-sheet lending now about a third of the book, the roughly 3%-of-revenue funding cost has not been stress-tested against a genuine tightening of onshore liquidity (Unit Economics). The third is the overseas business. Management's "1-core, 2-wings" push is live — the United Kingdom and a Latin American country launched in the first quarter of 2026, with Southeast Asia planned — but it is explicitly "still in the early stage of investment," and its size, unit economics, and whether it diversifies the single-country regulatory concentration are unquantified [27]. One structural overhang also sits unresolved: with the acting-in-concert arrangement terminated in December 2025, the 19.1% Aerovane block held by the founder's children is now ordinary stock, and how it is voted and whether it is eventually sold down are open (Founder Decoupling).
Where the balance sits
Held to the arithmetic, the weight of the evidence in this report sits between the base and bear cases and, on the most recent data, has edged toward the base. The discount is genuine rather than a pure trap: Qifu is the scale leader of its segment, it moved roughly US$0.9 billion to shareholders in 2025, the pricing shock the market feared was absorbed three years ago, and the leading credit indicators have begun to turn [28] [29]. The discount is also partly earned: the cheap earnings run off a lightly provisioned base, the book and the profit lean on one credit estimate, and the return engine paused just as the shares grew cheapest [30] [31].
What would move the read toward mispricing is a 90-day-plus rate that peaks in the second half of 2026, a non-GAAP profit that holds its floor, and a buyback resumed at these prices. What would confirm the trap is a deeper credit down-leg that pulls earnings and book down together, or an obstruction to getting the cash out. Both paths are observable within a few quarters, on lines that already exist in the quarterly release. For a buyer of cheap companies, the discount is large enough that the base case pays well and the bear case is survivable; the signals above are what turn that from a statement about price into a decision that can be checked against the record as it arrives.